Acurx & New to The Street Extend Media Partnership

Acurx Pharmaceuticals (NASDAQ: ACXP) and New to The Street have expanded their media partnership. The agreement includes television interviews, commercials, and investor events, aiming to increase Acurx's visibility within the biotech investment community.

Acurx Pharmaceuticals (NASDAQ: ACXP), a late-stage biopharmaceutical company, has renewed its comprehensive media partnership with New to The Street, a prominent financial media platform. This expanded agreement significantly increases Acurx‘s media presence.

The expanded partnership will utilize multiple channels to reach investors and the public. These include long-form television interviews on Bloomberg Television and Fox Business, national television commercials, and participation in exclusive investor forums hosted by AccreditedEvents.com.

New to The Street‘s extensive digital reach will also be leveraged. This includes promotion via its YouTube channel, boasting over 3.4 million subscribers, and various social media platforms such as LinkedIn, X, Facebook, and Instagram. High-impact outdoor advertising in New York City‘s Times Square and Financial District will further enhance visibility.

Vince Caruso, CEO and Co-Founder of New to The Street, expressed confidence in the partnership’s ability to effectively showcase Acurx‘s advancements in antibiotic development to a broad audience. He highlighted the multi-platform strategy’s effectiveness in generating consistent media exposure and strengthening Acurx‘s profile among biotech investors.

Acurx Pharmaceuticals is developing a novel class of antibiotics to combat difficult-to-treat bacterial infections. Their approach focuses on creating antibiotics with a Gram-positive selective spectrum that inhibits bacterial DNA replication. Their lead product candidate, ibezapolstat, is poised to enter Phase 3 clinical trials internationally next year, pending securing necessary funding. The company also has several preclinical programs underway, including an oral treatment for acute bacterial skin and skin structure infections and a potential inhaled anthrax treatment.

New to The Street has a long history in financial media, providing sponsored programming on major television networks for over 16 years. Their services offer a blend of long-form interviews, commercials, and social media marketing, designed to connect companies with both the public and accredited investors. The company’s strategic approach aims to provide predictable and consistent media exposure for its clients.

Share: X Facebook LinkedIn WhatsApp
Share your love